|
1
|
Brogi E: Carcinoma with metaplasia and
low-grade adenosquamous carcinoma. Rosen's Breast Pathology. 4th
edition. Lippincott Williams & Wilkins, Philadelphia, PA,
pp547-pp598, 2014.
|
|
2
|
Reis-Filho JS, Gobbi H, McCart Reed AE,
Rakha EA, Shin SJ, Sotiriou C and Vincent-Salomon A: Metaplastic
carcinoma. WHO Classification of Tumours Editorial Board. Breast
Tumours. 5th edition. International Agency for Research on Cancer,
Lyon, pp134-pp138, 2019.
|
|
3
|
Ong CT, Campbell BM, Thomas SM, Greenup
RA, Plichta JK, Rosenberger LH, Force J, Hall A, Hyslop T, Hwang ES
and Fayanju OM: Metaplastic breast cancer treatment and outcomes in
2,500 patients: A retrospective analysis of a national oncology
database. Ann Surg Oncol. 25:2249–2260. 2018.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Ordonez NG: SATB2 is a novel marker of
osteoblastic differentiation and colorectal adenocarcinoma. Adv
Anat Pathol. 21:63–67. 2014.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Mazur MT and Battifora HA: Adenoid cystic
carcinoma of the uterine cervix: Ultrastructure,
immunofluorescence, and criteria for diagnosis. Am J Clin Pathol.
77:494–500. 1982.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Jakobiec FA, Stagner AM, Eagle RC Jr,
Lally SE and Krane JF: Unusual pleomorphic adenoma of the lacrimal
gland: Immunohistochemical demonstration of PLAG1 and HMGA2
oncoproteins. Surv Ophthalmol. 62:219–226. 2017.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Asai S, Tang X, Ohta Y and Tsutsumi Y:
Myoepithelial carcinoma in pleomorphic adenoma of salivary gland
type, occurring in the mandible of an infant. Pathol Int.
45:677–683. 1995.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Kato N, Takeda J, Fukase M and Motoyama T:
Alternate mucoid and hyalinized stroma in clear cell carcinoma of
the ovary: Manifestation of serial stromal remodeling. Mod Pathol.
23:881–888. 2010.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Al-Obaidy KI, Williamson SR, Shelman N,
Idrees MT and Ulbright TM: Hepatoid Teratoma, Hepatoid yolk sac
tumor, and hepatocellular carcinoma: A morphologic and
immunohistochemical study of 30 cases. Am J Surg Pathol.
45:127–136. 2021.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Weber L, Krieg T, Müller PK, Kirsch E and
Timpl R: Immunofluorescent localization of type IV collagen and
laminin in human skin and its application in junctional zone
pathology. Br J Dermatol. 106:267–273. 1982.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Murrell TG: The potential for oxytocin
(OT) to prevent breast cancer: A hypothesis. Breast Cancer Res
Treat. 35:225–229. 1995.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Lepucki A, Orlińska K, Mielczarek-Palacz
A, Kabut J, Olczyk P and Komosińska-Vassev K: The role of
extracellular matrix proteins in breast cancer. J Clin Med.
11(1250)2022.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Gudjonsson T, Rønnov-Jessen L, Villadsen
R, Rank F, Bissell MJ and Petersen OW: Normal and tumor-derived
myoepithelial cells differ in their ability to interact with
luminal breast epithelial cells for polarity and basement membrane
deposition. J Cell Sci. 115:39–50. 2002.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Tavassoli FA and Soares J: Myoepithelial
lesions. In: Pathology and Genetics of Tumours of the Breast and
Female Genital Organs. Tavassoli FA and Devilee P (eds).
International Agency for Research on Cancer, Lyon, pp86-88,
2003.
|
|
15
|
Rakha EA, Coimbra ND, Hodi Z, Juneinah E,
Ellis IO and Lee AH: Immunoprofile of metaplastic carcinomas of the
breast. Histopathology. 70:975–985. 2017.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Cakir A, Isik Gonul I, Ekinci O, Cetin B,
Benekli M and Uluoglu O: GATA3 expression and its relationship with
clinicopathological parameters in invasive breast carcinomas.
Pathol Res Pract. 213:227–234. 2017.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Rayson D, Adjei AA, Suman VJ, Wold LE and
Ingle JN: Metaplastic breast cancer: Prognosis and response to
systemic therapy. Ann Oncol. 10:413–419. 1999.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Rakha EA, Tan PH, Varga Z, Tse GM, Shaaban
AM, Climent F, van Deurzen CH, Purnell D, Dodwell D, Chan T and
Ellis IO: Prognostic factors in metaplastic carcinoma of the
breast: A multi-institutional study. Br J Cancer. 112:283–289.
2015.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Frachon S, Pasquier D, Treilleux I,
Seigneurin D, Ringeisen F, Rosier P, Bolla M and Boutonnat J:
Breast carcinoma with predominant neuroendocrine differentiation.
Ann Pathol. 24:278–283. 2004.PubMed/NCBI View Article : Google Scholar : (In French).
|
|
20
|
Ding HY and Gao LX: Spindle cell carcinoma
of breast with neuroendocrine differentiation. Zhonghua Bing Li Xue
Za Zhi. 35:13–17. 2006.PubMed/NCBI(In Chinese).
|
|
21
|
Lai BS, Tsang JY, Poon IK, Shao Y, Chan
SK, Tam FK, Cheung SY, Shea KH and Tse GM: The clinical
significance of neuroendocrine features in invasive breast
carcinomas. Oncologist. 25:e1318–1329. 2020.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Rosen SE and Gattuso P: Neuroendocrine
tumors of the breast. Arch Pathol Lab Med. 141:1577–1581.
2017.PubMed/NCBI View Article : Google Scholar
|
